Rachel Jia

423 citations
16 papers · 256 indexed · h-index 10
Topics
Bladder and Urothelial Cancer Treatments (5 papers)Urinary and Genital Oncology Studies (5 papers)Endometrial and Cervical Cancer Treatments (3 papers)
Partner nations
United StatesSwedenItaly

In The Last Decade

Rachel Jia

16 papers receiving 250 citations

Peers

Rachel Jia
Comparison fields: 5 of 47
  • Surgery 150
  • Oncology 87
  • Otorhinolaryngology 83
  • Pulmonary and Respiratory Medicine 61
  • Molecular Biology 27
Replace Savitri C. Ritoe with:
Savitri C. Ritoe Netherlands
Sarah S. Kılıç United States
Y. Brewer France
Arun Chandrasekharan India
Rodger M. Pryzant United States
Hasan Çağrı Yıldırım Türkiye
F Lunghi Italy
Joel Sherman United States
Kartik Viswanathan United States
Ahmed Nadeem Abbası Pakistan
Rachel Jia relative to Savitri C. Ritoe Netherlands Savitri C. Ritoe's profile →
Citations per field
00.5×10×20×28×
Savitri C. Ritoe · 1×
Citations per year

Countries citing papers authored by Rachel Jia

Since Specialization
Citations

This map shows the geographic impact of Rachel Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Jia more than expected).

Fields of papers citing papers by Rachel Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Jia. The network helps show where Rachel Jia may publish in the future.

Co-authorship network of co-authors of Rachel Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Jia. A scholar is included among the top collaborators of Rachel Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Jia. Rachel Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 13
3 26
4 18
5 36
6 76
7 1
8 6
9 14
10 2
11 22
12 9
13 19
14 10
15 1
16 1

About Rachel Jia

Rachel Jia is a scholar working on Otorhinolaryngology, Oncology and Obstetrics and Gynecology, having authored 16 papers that have together received 256 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Urinary and Genital Oncology Studies (5 papers) and Endometrial and Cervical Cancer Treatments (3 papers). The work is most often cited by research in Otorhinolaryngology (83 citations), Surgery (150 citations) and Oncology (87 citations). Rachel Jia has collaborated with scholars based in United States, Sweden and Italy. Frequent co-authors include Matthew D. Galsky, Reza Mehrazin, John P. Sfakianos, Nikhil Waingankar, Kathryn E. Marqueen, Madhu Mazumdar, Bart S. Ferket, Vishal Gupta, Richard L. Bakst and Peter M. Som. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026